Your browser doesn't support javascript.
loading
A robust method for the estimation and visualization of IgE cross-reactivity likelihood between allergens belonging to the same protein family.
Chruszcz, Maksymilian; Kapingidza, A Brenda; Dolamore, Coleman; Kowal, Krzysztof.
Afiliação
  • Chruszcz M; Department of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina, United States of America.
  • Kapingidza AB; Department of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina, United States of America.
  • Dolamore C; Department of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina, United States of America.
  • Kowal K; Department of Allergology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.
PLoS One ; 13(11): e0208276, 2018.
Article em En | MEDLINE | ID: mdl-30496313
Among the vast number of identified protein families, allergens emanate from relatively few families which translates to only a small fraction of identified protein families. In allergy diagnostics and immunotherapy, interactions between immunoglobulin E and allergens are crucial because the formation of an allergen-antibody complex is necessary for triggering an allergic reaction. In allergic diseases, there is a phenomenon known as cross-reactivity. Cross-reactivity describes a situation where an individual has produced antibodies against a particular allergenic protein, but said antibodies fail to discriminate between the original sensitizer and other similar proteins that usually belong to the same family. To expound the concept of cross-reactivity, this study examines ten protein families that include allergens selected specifically for the analysis of cross-reactivity. The selected allergen families had at least 13 representative proteins, overall folds that differ significantly between families, and include relevant allergens with various potencies. The selected allergens were analyzed using information on sequence similarities and identities between members of the families as well as reports on clinically relevant cross-reactivities. Based on our analysis, we propose to introduce a new A-RISC index (Allergens'-Relative Identity, Similarity and Cross-reactivity) which describes homology between two allergens belonging to the same protein family and is used to predict the likelihood of cross-reactivity between them. Information on sequence similarities and identities, as well as on the values of the proposed A-RISC index is used to introduce four categories describing a risk of a cross-reactive reaction, namely: high, medium-high, medium-low and low. The proposed approach can facilitate analysis in component-resolved allergy diagnostics, generation of avoidance guidelines for allergic individuals, and help with the design of immunotherapy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina E / Alérgenos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina E / Alérgenos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article